Healthcare provider profile · identity verified

Andrew Prodromou, MD

Internal Medicine · SUNNYVALE, CA · NPI 1619984895

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	502	134
Amlodipine Besylate	Amlodipine Besylate	363	98
Levothyroxine Sodium	Levothyroxine Sodium	247	57
Losartan Potassium	Losartan Potassium	198	51
Lisinopril	Lisinopril	181	52
Pantoprazole Sodium	Pantoprazole Sodium	181	54
Simvastatin	Simvastatin	172	47
Atenolol	Atenolol	155	38
Tamsulosin Hcl	Tamsulosin Hcl	152	43
Gabapentin	Gabapentin	122	35
Metformin Hcl	Metformin Hcl	121	32
Metoprolol Succinate	Metoprolol Succinate	121	33
Allopurinol	Allopurinol	113	33
Pravastatin Sodium	Pravastatin Sodium	108	30
Prednisone	Prednisone	106	60
Rosuvastatin Calcium	Rosuvastatin Calcium	101	27
Omeprazole	Omeprazole	94	24
Metformin Hcl Er	Metformin Hcl	89	22
Furosemide	Furosemide	85	24
Sertraline Hcl	Sertraline Hcl	80	19
Trazodone Hcl	Trazodone Hcl	78	27
Doxazosin Mesylate	Doxazosin Mesylate	77	20
Triamcinolone Acetonide	Triamcinolone Acetonide	77	40
Eliquis	Apixaban	72	18
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	71	15
Meloxicam	Meloxicam	67	31
Alendronate Sodium	Alendronate Sodium	65	18
Escitalopram Oxalate	Escitalopram Oxalate	63	20
Zolpidem Tartrate	Zolpidem Tartrate	63	14
Fluticasone Propionate	Fluticasone Propionate	62	23
Jardiance	Empagliflozin	60	14
Azithromycin	Azithromycin	59	38
Finasteride	Finasteride	57	15
Hydrochlorothiazide	Hydrochlorothiazide	57	18
Glimepiride	Glimepiride	55	15
Mirtazapine	Mirtazapine	55	11
Amoxicillin	Amoxicillin	54	45
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	53	13
Potassium Chloride	Potassium Chloride	52	13
Donepezil Hcl	Donepezil Hcl	51	13
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	50	13
Hydromorphone Hcl	Hydromorphone Hcl	48	suppressed
Diazepam	Diazepam	47	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	47	16
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	47	15
Venlafaxine Hcl Er	Venlafaxine Hcl	46	12
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	45	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	45	suppressed
Trulicity	Dulaglutide	44	suppressed
Alprazolam	Alprazolam	43	11
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	43	33
Clopidogrel	Clopidogrel Bisulfate	43	12
Glipizide Er	Glipizide	42	11
Duloxetine Hcl	Duloxetine Hcl	41	suppressed
Lorazepam	Lorazepam	41	13
Valacyclovir	Valacyclovir Hcl	41	21
Nortriptyline Hcl	Nortriptyline Hcl	40	12
Bupropion Xl	Bupropion Hcl	38	suppressed
Synthroid	Levothyroxine Sodium	38	suppressed
Tizanidine Hcl	Tizanidine Hcl	38	suppressed
Clonazepam	Clonazepam	36	suppressed
Tramadol Hcl	Tramadol Hcl	36	13
Lovastatin	Lovastatin	35	suppressed
Cephalexin	Cephalexin	34	27
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	34	22
Xarelto	Rivaroxaban	34	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	33	20
Metoprolol Tartrate	Metoprolol Tartrate	33	11
Azelastine Hcl	Azelastine Hcl	32	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	31	suppressed
Digoxin	Digoxin	31	suppressed
Glipizide	Glipizide	31	suppressed
Spironolactone	Spironolactone	31	suppressed
Celecoxib	Celecoxib	30	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	30	30
Albuterol Sulfate Hfa	Albuterol Sulfate	29	11
Benazepril Hcl	Benazepril Hcl	29	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	29	20
Felodipine Er	Felodipine	28	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	28	11
Carvedilol	Carvedilol	27	suppressed
Warfarin Sodium	Warfarin Sodium	27	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	26	12
Pioglitazone Hcl	Pioglitazone Hcl	26	suppressed
Clonidine Hcl	Clonidine Hcl	25	suppressed
Ropinirole Hcl	Ropinirole Hcl	25	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	24	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	22	13
Esomeprazole Magnesium	Esomeprazole Magnesium	22	suppressed
Famotidine	Famotidine	22	suppressed
Fluconazole	Fluconazole	22	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	22	suppressed
Ezetimibe	Ezetimibe	20	suppressed
Fenofibrate	Fenofibrate	20	suppressed
Hydralazine Hcl	Hydralazine Hcl	20	suppressed
Valsartan	Valsartan	20	suppressed
Folic Acid	Folic Acid	19	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	19	suppressed
Butalb-Acetaminoph-Caff-Codein	Butalbit/Acetamin/Caff/Codeine	18	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	18	suppressed
Memantine Hcl	Memantine Hcl	18	suppressed
Percocet	Oxycodone Hcl/Acetaminophen	18	suppressed
Cefdinir	Cefdinir	17	suppressed
Estradiol	Estradiol	17	suppressed
Labetalol Hcl	Labetalol Hcl	17	suppressed
Terazosin Hcl	Terazosin Hcl	17	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	16	suppressed
Januvia	Sitagliptin Phosphate	16	suppressed
Morphine Sulfate Er	Morphine Sulfate	16	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	16	suppressed
Temazepam	Temazepam	16	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	16	suppressed
Hydrocortisone	Hydrocortisone	15	suppressed
Montelukast Sodium	Montelukast Sodium	14	suppressed
Nifedipine Er	Nifedipine	14	suppressed
Ondansetron Odt	Ondansetron	14	suppressed
Penicillin V Potassium	Penicillin V Potassium	14	suppressed
Colchicine	Colchicine	13	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	13	suppressed
Econazole Nitrate	Econazole Nitrate	13	suppressed
Ozempic	Semaglutide	13	suppressed
Pulmicort Flexhaler	Budesonide	13	suppressed
Ziprasidone Hcl	Ziprasidone Hcl	13	suppressed
Acyclovir	Acyclovir	12	suppressed
Dutasteride	Dutasteride	12	suppressed
Lactulose	Lactulose	12	suppressed
Mupirocin	Mupirocin	12	suppressed
Paroxetine Hcl	Paroxetine Hcl	12	suppressed
Prempro	Estrogen,con/M-Progest Acet	12	suppressed
Sucralfate	Sucralfate	12	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	11	suppressed
Buspirone Hcl	Buspirone Hcl	11	suppressed
Carisoprodol	Carisoprodol	11	suppressed
Citalopram Hbr	Citalopram Hydrobromide	11	suppressed
Doxepin Hcl	Doxepin Hcl	11	suppressed
Irbesartan	Irbesartan	11	suppressed
Levetiracetam	Levetiracetam	11	suppressed
Metronidazole	Metronidazole	11	suppressed
Mounjaro	Tirzepatide	11	suppressed
Nitrofurantoin	Nitrofurantoin Macrocrystal	11	suppressed
Oxymorphone Hcl Er	Oxymorphone Hcl	11	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	11	suppressed
Zolpidem Tartrate Er	Zolpidem Tartrate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error